Validate the signal
- Analyzed segment-level sales patterns and emerging customer behavior.
- Validated the structural-biology use case through voice-of-customer insight.
- Assessed the opportunity’s commercial relevance and right to win.
Case study
Converted emerging academic demand into a focused structural-biology segment strategy, differentiated positioning, and repeatable commercial model.
Executive summary
A technology introduced primarily for pharmaceutical biologics development began gaining meaningful traction among academic structural-biology researchers.
The academic segment was not part of the original growth plan, and the emerging use case was not reflected consistently in claims, messaging, targeting, or sales activation.
Segment-level sales data and voice-of-customer evidence revealed an underserved structural-biology opportunity with meaningful commercial potential.
Led the market development strategy and coordinated cross-functional activation of the emerging segment opportunity.
+322%
Structural-biology segment revenue growth
Recognized internally as a repeatable market expansion playbook.
Expanded the opportunity beyond the original pharma-focused growth plan.
Commercial impact
By combining segment-level evidence, customer insight, differentiated positioning, and focused commercial model, the team converted an overlooked academic signal into sustained structural-biology growth. The result was not simply growth in a new segment—it was a repeatable method for identifying and activating adjacent market opportunities.
Interested in discussing a leadership opportunity, commercial challenge, or strategic growth priority?